We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VTGN market cap is 128.37M. The company's latest EPS is USD -2.1923 and P/E is -2.17.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 180k | 176k | 178k | 277k | 412k |
| Operating Income | -9.77M | -12.24M | -7M | -6.78M | -7.88M |
| Net Income | -9.76M | -12.23M | -6.9M | -6.59M | -6.35M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 1.09M | 1.11M | -227k |
| Operating Income | -24.56M | -20.8M | -17.93M | -47.78M | -59.27M |
| Net Income | -25.73M | -22.04M | -42.32M | -48.71M | -59.25M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.71M | 21.09M | 15.03M | 42.2M | 131.07M |
| Total Liabilities | 9.04M | 9.01M | 8.18M | 6.55M | 7.78M |
| Total Equity | 20.67M | 12.08M | 6.85M | 35.65M | 123.29M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.01M | 5.77M | 108.28M | 74.64M | 21.09M |
| Total Liabilities | 6.94M | 11.5M | 16.3M | 9.93M | 9.01M |
| Total Equity | 7.08M | -5.73M | 91.98M | 64.72M | 12.08M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.24M | -49.72M | -7.89M | -14.08M | -18.62M |
| Investing | -212k | -740k | N/A | N/A | -32k |
| Financing | -644k | -1.04M | 875k | 35.05M | 128.57M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.53M | -15.76M | -12.07M | -45.26M | -49.72M |
| Investing | -174k | N/A | -275k | -200k | -740k |
| Financing | 17.42M | 4.01M | 114.1M | 10.48M | -1.04M |
| Market Cap | 128.37M |
| Price to Earnings Ratio | -2.17 |
| Price to Sales Ratio | -566.67 |
| Price to Cash Ratio | 7.73 |
| Price to Book Ratio | 10.65 |
| Dividend Yield | - |
| Shares Outstanding | 27.03M |
| Average Volume (1 week) | 160.69k |
| Average Volume (1 Month) | 243.26k |
| 52 Week Change | 14.82% |
| 52 Week High | 24.71 |
| 52 Week Low | 1.62 |
| Spread (Intraday) | 0.15 (3.1%) |
| Company Name | VistaGen Therapeutics Inc |
| Address |
701 s carson st ste 200 carson city, nevada 89701 |
| Website | https://www.vistagen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
